Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06689410Not ApplicableRecruiting

Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms

Role: collaborator

NCT05030740Completed

French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft

Role: collaborator

NCT04592185Unknown

The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms

Role: collaborator

NCT01796769Phase 4Unknown

Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform for Improving CPAP Compliance in Low Cardiovascular Risk Sleep Apnea Patients : OPTISAS 1 Study

Role: collaborator

NCT01505959Phase 4Unknown

Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study

Role: collaborator

All 5 trials loaded